{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T20:42:36Z","timestamp":1784234556837,"version":"3.55.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T00:00:00Z","timestamp":1730851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T00:00:00Z","timestamp":1730851200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Rheumatol"],"DOI":"10.1186\/s41927-024-00427-1","type":"journal-article","created":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T04:41:38Z","timestamp":1730868098000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Prevalence of co-existing autoimmune and autoinflammatory diseases in vitiligo: a survey-based study from Egypt"],"prefix":"10.1186","volume":"8","author":[{"given":"Samar","family":"Tharwat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatma","family":"Hamdy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Hamdy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed Kamal","family":"Nassar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,6]]},"reference":[{"issue":"9","key":"427_CR1","doi-asserted-by":"publisher","first-page":"e0163806","DOI":"10.1371\/journal.pone.0163806","volume":"11","author":"Y Zhang","year":"2016","unstructured":"Zhang Y, Cai Y, Shi M, Jiang S, Cui S, Wu Y, et al. The prevalence of vitiligo: a meta-analysis. PLoS ONE. 2016;11(9):e0163806.","journal-title":"PLoS ONE"},{"issue":"2","key":"427_CR2","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.det.2016.11.002","volume":"35","author":"N Elbuluk","year":"2017","unstructured":"Elbuluk N, Ezzedine K. Quality of life, burden of disease, co-morbidities, and systemic effects in vitiligo patients. Dermatol Clin. 2017;35(2):117\u201328.","journal-title":"Dermatol Clin"},{"issue":"1","key":"427_CR3","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.det.2019.08.005","volume":"38","author":"R Zubair","year":"2020","unstructured":"Zubair R, Hamzavi IH. Phototherapy for vitiligo. Dermatol Clin. 2020;38(1):55\u201362.","journal-title":"Dermatol Clin"},{"key":"427_CR4","doi-asserted-by":"publisher","first-page":"986918","DOI":"10.3389\/fimmu.2022.986918","volume":"13","author":"Y Feng","year":"2022","unstructured":"Feng Y, Lu Y. Advances in vitiligo: update on therapeutic targets. Front Immunol. 2022;13:986918.","journal-title":"Front Immunol"},{"issue":"1","key":"427_CR5","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3109\/08916930108994127","volume":"34","author":"EH Kemp","year":"2001","unstructured":"Kemp EH, Waterman EA, Weetman AP. Autoimmune aspects of vitiligo. Autoimmunity. 2001;34(1):65\u201377.","journal-title":"Autoimmunity"},{"issue":"10","key":"427_CR6","doi-asserted-by":"publisher","first-page":"2174","DOI":"10.1016\/j.jid.2019.03.1148","volume":"139","author":"T Cui","year":"2019","unstructured":"Cui T, Zhang W, Li S, Chen X, Chang Y, Yi X, et al. Oxidative stress\u2013induced HMGB1 release from melanocytes: a paracrine mechanism underlying the cutaneous inflammation in vitiligo. J Invest Dermatology. 2019;139(10):2174\u201384. e4.","journal-title":"J Invest Dermatology"},{"key":"427_CR7","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1146\/annurev-immunol-100919-023531","volume":"38","author":"ML Frisoli","year":"2020","unstructured":"Frisoli ML, Essien K, Harris JE. Vitiligo: mechanisms of pathogenesis and treatment. Annu Rev Immunol. 2020;38:621\u201348.","journal-title":"Annu Rev Immunol"},{"issue":"9","key":"427_CR8","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/j.autrev.2017.07.005","volume":"16","author":"R Speeckaert","year":"2017","unstructured":"Speeckaert R, Speeckaert M, De Schepper S, van Geel N. Biomarkers of disease activity in vitiligo: a systematic review. Autoimmun rev. 2017;16(9):937\u201345.","journal-title":"Autoimmun rev"},{"issue":"4","key":"427_CR9","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1111\/ijd.14695","volume":"59","author":"N Bernardini","year":"2020","unstructured":"Bernardini N, Skroza N, Tolino E, Mambrin A, Anzalone A, Balduzzi V, et al. IL-17 and its role in inflammatory, autoimmune, and oncological skin diseases: state of art. Int J Dermatol. 2020;59(4):406\u201311.","journal-title":"Int J Dermatol"},{"issue":"1","key":"427_CR10","doi-asserted-by":"publisher","first-page":"43","DOI":"10.4161\/derm.1.1.7306","volume":"1","author":"M Tanioka","year":"2009","unstructured":"Tanioka M, Yamamoto Y, Katoh M, Takahashi K, Miyachi Y. Vitiligo Vulgaris and autoimmune diseases in Japan: a report from vitiligo clinic in Kyoto University Hospital. Dermato-Endocrinology. 2009;1(1):43\u20135.","journal-title":"Dermato-Endocrinology"},{"issue":"3","key":"427_CR11","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s12016-021-08868-z","volume":"61","author":"Y Wang","year":"2021","unstructured":"Wang Y, Li S, Li C. Clinical features, immunopathogenesis, and therapeutic strategies in vitiligo. Clin Rev Allergy Immunol. 2021;61(3):299\u2013323.","journal-title":"Clin Rev Allergy Immunol"},{"issue":"4","key":"427_CR12","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1177\/120347541201600408","volume":"16","author":"J Sawicki","year":"2012","unstructured":"Sawicki J, Siddha S, Rosen C. Vitiligo and associated autoimmune disease: retrospective review of 300 patients. J Cutan Med Surg. 2012;16(4):261\u20136.","journal-title":"J Cutan Med Surg"},{"issue":"10","key":"427_CR13","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1111\/ijd.14055","volume":"57","author":"AM Dahir","year":"2018","unstructured":"Dahir AM, Thomsen SF. Comorbidities in vitiligo: comprehensive review. Int J Dermatol. 2018;57(10):1157\u201364.","journal-title":"Int J Dermatol"},{"issue":"3","key":"427_CR14","first-page":"14","volume":"81","author":"Association GAotWM","year":"2014","unstructured":"Association GAotWM. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. J Am Coll Dent. 2014;81(3):14\u20138.","journal-title":"J Am Coll Dent"},{"issue":"4","key":"427_CR15","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1001\/archderm.135.4.407","volume":"135","author":"M Njoo","year":"1999","unstructured":"Njoo M, Das P, Bos J, Westerhof W. Association of the K\u00f6bner phenomenon with disease activity and therapeutic responsiveness in vitiligo vulgaris. Arch Dermatol. 1999;135(4):407\u201313.","journal-title":"Arch Dermatol"},{"issue":"6","key":"427_CR16","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.aller.2010.12.007","volume":"39","author":"S Poojary","year":"2011","unstructured":"Poojary S. Vitiligo and associated autoimmune disorders: a retrospective hospital-based study in Mumbai, India. Allergol Immunopathol. 2011;39(6):356\u201361.","journal-title":"Allergol Immunopathol"},{"issue":"4","key":"427_CR17","doi-asserted-by":"publisher","first-page":"505","DOI":"10.2332\/allergolint.11-OA-0303","volume":"60","author":"T Narita","year":"2011","unstructured":"Narita T, Oiso N, Fukai K, Kabashima K, Kawada A, Suzuki T. Generalized vitiligo and associated autoimmune diseases in Japanese patients and their families. Allergology Int. 2011;60(4):505\u20138.","journal-title":"Allergology Int"},{"issue":"2","key":"427_CR18","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.jaad.2015.08.063","volume":"74","author":"L Gill","year":"2016","unstructured":"Gill L, Zarbo A, Isedeh P, Jacobsen G, Lim HW, Hamzavi I. Comorbid autoimmune diseases in patients with vitiligo: a cross-sectional study. J Am Acad Dermatol. 2016;74(2):295\u2013302.","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"427_CR19","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1159\/000357807","volume":"228","author":"V Ingordo","year":"2014","unstructured":"Ingordo V, Cazzaniga S, Raone B, Digiuseppe MD, Musumeci ML, Fai D, et al. Circulating autoantibodies and autoimmune comorbidities in vitiligo patients: a multicenter Italian study. Dermatology. 2014;228(3):240\u20139.","journal-title":"Dermatology"},{"issue":"10391","key":"427_CR20","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1016\/S0140-6736(23)00457-9","volume":"401","author":"N Conrad","year":"2023","unstructured":"Conrad N, Misra S, Verbakel JY, Verbeke G, Molenberghs G, Taylor PN, et al. Incidence, prevalence, and co-occurrence of autoimmune disorders over time and by age, sex, and socioeconomic status: a population-based cohort study of 22 million individuals in the UK. Lancet. 2023;401(10391):1878\u201390.","journal-title":"Lancet"},{"key":"427_CR21","doi-asserted-by":"publisher","first-page":"102266","DOI":"10.1016\/j.coi.2022.102266","volume":"80","author":"FW Miller","year":"2023","unstructured":"Miller FW. The increasing prevalence of autoimmunity and autoimmune diseases: an urgent call to action for improved understanding, diagnosis, treatment, and prevention. Curr Opin Immunol. 2023;80:102266.","journal-title":"Curr Opin Immunol"},{"key":"427_CR22","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1590\/S0365-05962011000200006","volume":"86","author":"DH Nunes","year":"2011","unstructured":"Nunes DH, Esser LMH. Vitiligo epidemiological profile and the association with thyroid disease. An Bras Dermatol. 2011;86:241\u20138.","journal-title":"An Bras Dermatol"},{"key":"427_CR23","doi-asserted-by":"crossref","unstructured":"Vachiramon V, Harnchoowong S, Onprasert W, Chanprapaph K. Prevalence of thyroid abnormalities in thai patients with vitiligo. BioMed research international. 2017;2017.","DOI":"10.1155\/2017\/7502935"},{"issue":"5","key":"427_CR24","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.jaad.2016.12.034","volume":"76","author":"JM Bae","year":"2017","unstructured":"Bae JM, Lee JH, Yun JS, Han B, Han TY. Vitiligo and overt thyroid diseases: a nationwide population-based study in Korea. J Am Acad Dermatol. 2017;76(5):871\u20138.","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"427_CR25","doi-asserted-by":"publisher","first-page":"397","DOI":"10.5114\/ada.2022.115891","volume":"39","author":"S K\u0131l\u0131c","year":"2022","unstructured":"K\u0131l\u0131c S, \u015eehito\u011flu H, G\u00fcl C. Assessment of ADAM17 and ADAM10 proteins with CXCL10 and thyroid autoimmunity in vitiligo pathogenesis. Adv Dermatology Allergology\/Post\u0119py Dermatologii i Alergologii. 2022;39(2):397\u2013400.","journal-title":"Adv Dermatology Allergology\/Post\u0119py Dermatologii i Alergologii"},{"key":"427_CR26","doi-asserted-by":"crossref","unstructured":"Kasumagic-Halilovic E, Prohic A, Begovic B, Ovcina-Kurtovic N. Association between vitiligo and thyroid autoimmunity. Journal of thyroid research. 2011;2011.","DOI":"10.4061\/2011\/938257"},{"issue":"5","key":"427_CR27","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.jid.2022.10.021","volume":"143","author":"JH Lee","year":"2023","unstructured":"Lee JH, Ju HJ, Seo JM, Almurayshid A, Kim GM, Ezzedine K, et al. Comorbidities in patients with vitiligo: a systematic review and meta-analysis. J Invest Dermatology. 2023;143(5):777\u201389. e6.","journal-title":"J Invest Dermatology"},{"issue":"4","key":"427_CR28","doi-asserted-by":"publisher","first-page":"619","DOI":"10.4103\/jfmpc.jfmpc_344_22","volume":"12","author":"L Khiangte","year":"2023","unstructured":"Khiangte L, Lalrindik C. Study of thyroid disorders in vitiligo. J Family Med Prim Care. 2023;12(4):619.","journal-title":"J Family Med Prim Care"},{"key":"427_CR29","doi-asserted-by":"crossref","unstructured":"Prashant P, Garg R, Bansal P, Praveen S. PRASHANT P. Thyroid autoimmunity in Vitiligo: a case-control study. Cureus. 2023;15(1).","DOI":"10.7759\/cureus.34031"},{"issue":"4","key":"427_CR30","doi-asserted-by":"publisher","first-page":"357","DOI":"10.4103\/0019-5154.135485","volume":"59","author":"Y Yang","year":"2014","unstructured":"Yang Y, Huang G, Yan X, Qing Z. Clinical analysis of thyroglobulin antibody and thyroid peroxidase antibody and their association with vitiligo. Indian J Dermatology. 2014;59(4):357.","journal-title":"Indian J Dermatology"},{"issue":"5","key":"427_CR31","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1093\/ced\/llad028","volume":"48","author":"H Kang","year":"2023","unstructured":"Kang H, Lee S. Prevalence and incidence of vitiligo and associated comorbidities: a nationwide population-based study in Korea. Clin Exp Dermatol. 2023;48(5):484\u20139.","journal-title":"Clin Exp Dermatol"},{"key":"427_CR32","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s40257-018-0394-1","volume":"20","author":"H Yen","year":"2019","unstructured":"Yen H, Chi C-C. Association between psoriasis and vitiligo: a systematic review and meta-analysis. Am J Clin Dermatol. 2019;20:31\u201340.","journal-title":"Am J Clin Dermatol"},{"issue":"3","key":"427_CR33","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s00403-022-02358-8","volume":"315","author":"K Kridin","year":"2023","unstructured":"Kridin K, Lyakhovitsky K, Onn E, Lyakhovitsky A, Ludwig R, Weinstein O, et al. Investigating the epidemiological relationship between vitiligo and psoriasis: a population-based study. Arch Dermatol Res. 2023;315(3):395\u2013400.","journal-title":"Arch Dermatol Res"},{"issue":"4","key":"427_CR34","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1093\/ced\/llac104","volume":"48","author":"S Holmes","year":"2023","unstructured":"Holmes S, Harries M, Macbeth AE, Chiu WS, de Lusignan S, Messenger AG, et al. Alopecia Areata and risk of atopic and autoimmune conditions: population-based cohort study. Clin Exp Dermatol. 2023;48(4):325\u201331.","journal-title":"Clin Exp Dermatol"},{"issue":"7","key":"427_CR35","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1111\/jdv.12870","volume":"29","author":"Y Chen","year":"2015","unstructured":"Chen Y, Chen Y, Hwang C, Lin M, Chen T, Chen C, et al. Comorbidity profiles in association with vitiligo: a nationwide population-based study in Taiwan. J Eur Acad Dermatol Venereol. 2015;29(7):1362\u20139.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"427_CR36","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1046\/j.1365-2230.2000.00574.x","volume":"25","author":"A Barnadas","year":"2000","unstructured":"Barnadas A. Subcutaneous sarcoidosis associated with vitiligo, pernicious anaemia and autoimmune thyroiditis. Clin Exp Dermatol. 2000;25(1):55\u20136.","journal-title":"Clin Exp Dermatol"},{"key":"427_CR37","doi-asserted-by":"publisher","first-page":"754","DOI":"10.4103\/0378-6323.102380","volume":"78","author":"N Chhabra","year":"2012","unstructured":"Chhabra N, Pandhi D, Verma P, Singal A. Pleomorphic cutaneous sarcoidosis confined to lesions of vitiligo vulgaris in a patient with type 1 diabetes mellitus. Indian J Dermatol Venereol Leprol. 2012;78:754.","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"12","key":"427_CR38","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1111\/j.1346-8138.2007.00394.x","volume":"34","author":"SS Demirkoek","year":"2007","unstructured":"Demirkoek SS, Arzuhal N, Devrano\u011flu G, Demirkesen C, Tuezuen Y. Recurrent sarcoidosis on a scar associated with vitiligo. J Dermatol. 2007;34(12):829\u201333.","journal-title":"J Dermatol"},{"issue":"7","key":"427_CR39","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1046\/j.1365-4362.2000.00819-1.x","volume":"39","author":"A Terunuma","year":"2000","unstructured":"Terunuma A, Watabe A, Kato T, Tagami H. Coexistence of vitiligo and sarcoidosis in a patient with circulating autoantibodies. Int J Dermatol. 2000;39(7):551\u20133.","journal-title":"Int J Dermatol"},{"issue":"3","key":"427_CR40","doi-asserted-by":"publisher","first-page":"249","DOI":"10.31486\/toj.21.0098","volume":"22","author":"BT Thrash","year":"2022","unstructured":"Thrash BT, Pantlin PG, Mize BC, Rutner CC, Shaw CA, McCarron RE. Acute Vitiligo Repigmentation in the setting of suspected pulmonary sarcoidosis. Ochsner J. 2022;22(3):249\u201352.","journal-title":"Ochsner J"},{"issue":"6","key":"427_CR41","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1016\/j.jaad.2019.06.022","volume":"81","author":"H-C Chang","year":"2019","unstructured":"Chang H-C, Lin M-H, Huang Y-C, Hou T-Y. The association between vitiligo and diabetes mellitus: a systematic review and meta-analysis. J Am Acad Dermatol. 2019;81(6):1442\u20135.","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"427_CR42","first-page":"629","volume":"20","author":"P Kang","year":"2022","unstructured":"Kang P, Zhang WG, Ji ZH, Shao ZJ, Li CY. Association between Vitiligo and relevant components of metabolic syndrome: a systematic review and meta-analysis. JDDG: J Der Deutschen Dermatologischen Gesellschaft. 2022;20(5):629\u201341.","journal-title":"JDDG: J Der Deutschen Dermatologischen Gesellschaft"},{"issue":"12","key":"427_CR43","doi-asserted-by":"publisher","first-page":"7170","DOI":"10.1111\/jocd.15446","volume":"21","author":"S Ibrahim","year":"2022","unstructured":"Ibrahim S, El-Tahlawi S, Mogawer RM, El Ansary M, Esmat S, El\u2010Hawary M. Different vitiligo characteristics as predictors of increased risk of metabolic syndrome and insulin resistance: a case\u2013control study. J Cosmet Dermatol. 2022;21(12):7170\u20137.","journal-title":"J Cosmet Dermatol"},{"issue":"5","key":"427_CR44","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1111\/bjd.21704","volume":"187","author":"MC Schneeweiss","year":"2022","unstructured":"Schneeweiss MC, Kirchgesner J, Wyss R, Jin Y, York C, Merola JF, et al. Occurrence of inflammatory bowel disease in patients with chronic inflammatory skin diseases: a cohort study. Br J Dermatol. 2022;187(5):692\u2013703.","journal-title":"Br J Dermatol"},{"issue":"1","key":"427_CR45","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1111\/jdv.13759","volume":"31","author":"L M\u00e9ry-Bossard","year":"2017","unstructured":"M\u00e9ry-Bossard L, Bagny K, Chaby G, Khemis A, Maccari F, Marotte H, et al. New\u2010onset vitiligo and progression of pre\u2010existing vitiligo during treatment with biological agents in chronic inflammatory diseases. J Eur Acad Dermatol Venereol. 2017;31(1):181\u20136.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5","key":"427_CR46","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.3390\/jcm10051040","volume":"10","author":"JL Lambert","year":"2021","unstructured":"Lambert JL, De Schepper S, Speeckaert R. Cutaneous manifestations in biological-treated inflammatory bowel disease patients: a narrative review. J Clin Med. 2021;10(5):1040.","journal-title":"J Clin Med"},{"issue":"4","key":"427_CR47","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.jid.2017.11.012","volume":"138","author":"JM Bae","year":"2018","unstructured":"Bae JM, Kim M, Lee HH, Kim K-J, Shin H, Ju HJ, et al. Increased risk of vitiligo following anti-tumor necrosis factor therapy: a 10-year population-based cohort study. J Invest Dermatology. 2018;138(4):768\u201374.","journal-title":"J Invest Dermatology"},{"key":"427_CR48","doi-asserted-by":"crossref","unstructured":"Alhebshi A, Abbas H, Alotaibi HM, Attaf M, Al-Yamani A, Al-Hebshi A. A Saudi child with chronic Immune Thrombocytopenia and Vitiligo. Cureus. 2020;12(7).","DOI":"10.7759\/cureus.9314"},{"issue":"2","key":"427_CR49","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.jdcr.2019.12.007","volume":"6","author":"KT Nguyen","year":"2020","unstructured":"Nguyen KT, Gwinn CC, Vary JC Jr. Rituximab treatment for dermatitis herpetiformis in the setting of type 1 diabetes mellitus, celiac disease, vitiligo, autoimmune hemolytic anemia, and autoimmune thrombocytopenia. JAAD Case Rep. 2020;6(2):122\u20133.","journal-title":"JAAD Case Rep"},{"issue":"9","key":"427_CR50","doi-asserted-by":"publisher","first-page":"2597","DOI":"10.1007\/s00403-023-02661-y","volume":"315","author":"JA Rios-Duarte","year":"2023","unstructured":"Rios-Duarte JA, Sanchez-Zapata MJ, Silverberg JI. Association of vitiligo with multiple cutaneous and extra-cutaneous autoimmune diseases: a nationwide cross-sectional study. Arch Dermatol Res. 2023;315(9):2597\u2013603.","journal-title":"Arch Dermatol Res"},{"key":"427_CR51","doi-asserted-by":"publisher","first-page":"705796","DOI":"10.3389\/fmed.2021.705796","volume":"8","author":"AM Abu El-Asrar","year":"2021","unstructured":"Abu El-Asrar AM, Van Damme J, Struyf S, Opdenakker G. New perspectives on the immunopathogenesis and treatment of uveitis associated with Vogt-Koyanagi-Harada disease. Front Med. 2021;8:705796.","journal-title":"Front Med"},{"key":"427_CR52","doi-asserted-by":"crossref","unstructured":"Ma Z, Cao P, Cai M, Lin Q, Long X, Ge M et al. Characteristics of vitiligo patients with versus without associated autoimmune thyroid disease. Int J Dermatol. 2023.","DOI":"10.1111\/ijd.16951"}],"container-title":["BMC Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41927-024-00427-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41927-024-00427-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41927-024-00427-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T04:43:44Z","timestamp":1730868224000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcrheumatol.biomedcentral.com\/articles\/10.1186\/s41927-024-00427-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,6]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["427"],"URL":"https:\/\/doi.org\/10.1186\/s41927-024-00427-1","relation":{},"ISSN":["2520-1026"],"issn-type":[{"value":"2520-1026","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,6]]},"assertion":[{"value":"2 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The present study was carried out in adherence to the guidelines outlined in the Helsinki Declaration [].Furthermore, the Institutional Research Board of the Faculty of Medicine at Mansoura University granted approval for the study protocol. (approval registration number: R.24.02.2494.R2). All individuals who consented to partake in the research were redirected to the Google Form. Informed consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}},{"value":"Not Applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"59"}}